73 FR 10 pgs. 2507-2509 - Advisory Committees; Tentative Schedule of Meetings for 2008
Type: NOTICEVolume: 73Number: 10Pages: 2507 - 2509
FR document: [FR Doc. E8-567 Filed 1-14-08; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative Schedule of Meetings for 2008
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2008. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register . This publication implements the IOM's recommendation.
FOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
SUPPLEMENTARY INFORMATION:
The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register ; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register . However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/oc/advisory/default.htm . FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory committee meetings for 2008. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).
| Committee Name | Tentative Date of Meeting(s) | Advisory Committee 10-Digit Information Line Code |
|---|---|---|
| OFFICE OF THE COMMISSIONER | ||
| Pediatric Advisory Committee | March and November days to be announced | 8732310001 |
| Risk Communication Advisory Committee | February 28-29, May 15-16, August 21-22, November 17-18 | 8732112560 |
| Science Board to FDA | May and October days to be announced | 3014512603 |
| CENTER FOR BIOLOGICS EVALUATION AND RESEARCH | ||
| Allergenic Products Advisory Committee | April 29, October 17 | 3014512388 |
| Blood Products Advisory Committee | May 1-2, August 14-15, December 11-12 | 3014519516 |
| Cellular, Tissue and Gene Therapies Advisory Committee | April 10-11, November 13-14 | 3014512389 |
| Transmissible Spongiform Encephalopathies Advisory Committee | To be announced | 3014512392 |
| Vaccines and Related Biological Products Advisory Committee | February 20-21, May 21-22, September 24-25, November 19-20 | 3014512391 |
| CENTER FOR DRUG EVALUATION AND RESEARCH | ||
| Anesthetic and Life Support Drugs Advisory Committee | March 11, May days to be announced | 3014512529 |
| Anti-Infective Drugs Advisory Committee | February 27-28, April 1-3 | 3014512530 |
| Antiviral Drugs Advisory Committee | To be announced | 3014512531 |
| Arthritis Advisory Committee | July, September, and November days to be announced | 3014512532 |
| Cardiovascular and Renal Drugs Advisory Committee | June 24-25, August 19-20, December 9-10 | 3014512533 |
| Dermatologic and Ophthalmic Drugs Advisory Committee | April days to be announced | 3014512534 |
| Drug Safety and Risk Management Advisory Committee | February 1, May days to be announced | 3014512535 |
| Endocrinologic and Metabolic Drugs Advisory Committee | April 16-17, July 1-2, October 29-30, November 19-20 | 3014512536 |
| Gastrointestinal Drugs Advisory Committee | January 23, May days to be announced | 3014512538 |
| Nonprescription Drugs Advisory Committee | To be announced | 3014512541 |
| Oncologic Drugs Advisory Committee | March 13, April days to be announced, May 30, September 10-11, December 15-16 | 3014512542 |
| Peripheral and Central Nervous System Drugs Advisory Committee | May days to be announced | 3014512543 |
| Pharmaceutical Science and Clinical Pharmacology, Advisory Committee for | March 18-19 | 3014512539 |
| Psychopharmacologic Drugs Advisory Committee | February 6 | 3014512544 |
| Pulmonary-Allergy Drugs Advisory Committee | February 20 | 3014512545 |
| Reproductive Health Drugs, Advisory Committee for | To be announced | 3014512537 |
| CENTER FOR DEVICES AND RADIOLOGICAL HEALTH | ||
| Device Good Manufacturing Practice Advisory Committee | August 12, October 20-21 | 3014512398 |
| Medical Devices Advisory Committee (Comprised of 18 Panels) | ||
| Anesthesiology and Respiratory Therapy Devices Panel | January 23, March 26, September 17 | 3014512624 |
| Circulatory System Devices Panel | August 26-27, November 14-15 | 3014512625 |
| Clinical Chemistry and Clinical Toxicology Devices Panel | April 9-10, August 13-14, December 4-5 | 3014512514 |
| Dental Products Panel | June 11, September 10, November 19 | 3014512518 |
| Ear, Nose, and Throat Devices Panel | April 16-17, June 25-26, August 28-29, October 28-29, December 10-11 | 3014512522 |
| Gastroenterology-Urology Devices Panel | October 17 | 3014512523 |
| General and Plastic Surgery Devices Panel | June 10-11, October 21-22 | 3014512519 |
| General Hospital and Personal Use Devices Panel | May 6-7, September 16-17 | 3014512520 |
| Hematology and Pathology Devices Panel | April 25, October 17 | 3014512515 |
| Immunology Devices Panel | November 6-7 | 3014512516 |
| Medical Devices Dispute Resolution Panel | To be announced as needed | 3014510232 |
| Microbiology Devices Panel | April 24-25, June 19-20, October 23-24 | 3014512517 |
| Molecular and Clinical Genetics Panel | May 6-7, November 11-12 | 3014510231 |
| Neurological Devices Panel | March 25-26, June 3-4, September 23-24, November 6-7 | 3014512513 |
| Obstetrics and Gynecology Devices Panel | April 17-18, June 19-20, August 14-15, October 16-17, December 11-12 | 3014512524 |
| Ophthalmic Devices Panel | February 21-22, May 15-16, September 18-19, November 20-21 | 3014512396 |
| Orthopedic and Rehabilitation Devices Panel | April 21-22, June 16-17, August 18-19, October 20-21, December 8-9 | 3014512521 |
| Radiological Devices Panel | April 15-16, August 12, November 4 | 3014512526 |
| National Mammography Quality Assurance Advisory Committee | October 13-14 | 3014512397 |
| Technical Electronic Product Radiation Safety Standards Committee | October 8 | 3014512399 |
| CENTER FOR FOOD SAFETY AND APPLIED NUTRITION | ||
| Food Advisory Committee | July 22, December 2 | 3014510564 |
| CENTER FOR VETERINARY MEDICINE | ||
| Veterinary Medicine Advisory Committee | March day to be announced | 3014512548 |
| National Center for Toxicological Research (NCTR) | ||
| Science Advisory Board to NCTR | August 12-13 | 3014512559 |
Dated: January 7, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-567 Filed 1-14-08; 8:45 am]
BILLING CODE 4160-01-S